Establishment Labs, the manufacturer of Motiva® products, is a women’s health company that is committed to achieving safety through innovation. As such, our focus has always been – and will always be – the safety and satisfaction of our patients.
Surrounded by competitors that still use relatively old technology in their implants (i.e. from the last five generations), we firmly believe patients deserve to reap the benefits of technological evolution – which is exactly what makes our sixth-generation implants stand out.
Over more than a decade, Establishment Labs has built a body of scientific research on breast implant surfaces and the human immune system response. A combination of this research, product development, and technological innovation has culminated in the creation of the Motiva® product line.
Safety and performance data collected through our robust Post-Market Surveillance System and other extensive clinical research confirm that our SmoothSilk® / SilkSurface® shell contributes to improved post-operative outcomes, with patients reporting fewer high- and low-risk complications.
In particular, the data demonstrated a very low (less than 1%) capsular contracture rate in patients with SmoothSilk®/SilkSurface®.